386900007: Palivizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Palivizumab (substance)
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Palivizumab (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Palivizumab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Palivizumab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Palivizumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Palivizumab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Palivizumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Palivizumab (substance)	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Palivizumab (substance)	Is a	Substance with antiviral mechanism of action (substance)	true	Inferred relationship	Some
Palivizumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Palivizumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Palivizumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiviral (disposition)	true	Inferred relationship	Some
Palivizumab (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing palivizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palivizumab (substance)	Inferred relationship	Some	1
palivuzimab 50 mg, fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Palivizumab (substance)	Inferred relationship	Some
Palivizumab 100mg injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Palivizumab (substance)	Inferred relationship	Some
Palivizumab 100mg powder for injection 1mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Palivizumab (substance)	Inferred relationship	Some
palivizumab 100 mg, fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Palivizumab (substance)	Inferred relationship	Some
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Palivizumab (substance)	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab 50 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab 50 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palivizumab (substance)	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Palivizumab (substance)	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Palivizumab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461078016	Palivizumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481014019	Palivizumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
52241000195115	palivizumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
76391000087119	anticorps monoclonal contre le virus respiratoire syncytial	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
830751000172117	palivizumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
66571000195115	Palivizumab	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module